Cyclerion Therapeutics, Inc. — Director's Dealing 2021

Jun 28, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cyclerion Therapeutics, Inc. (CYCN)
CIK: 0001755237
Period of Report: 2021-06-24

Reporting Person: Fanucci Marsha (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-24	Stock Option (Right to Buy)	$3.97	A	10000	Acquired	2031-06-24	Common Stock (10000)	Direct

Footnotes

F1: The options, granted pursuant to the director compensation plan, will vest in full on the first anniversary of the grant date.